bio-technology general corp. received tenders for 97.9 % of its 7.5 % convertible senior subordinated notes due april 15 , 1997 , and 96 % of its 11 % convertible senior subordinated debentures due march 1 , 2006 . in exchange offers that expired friday , holders of each $ 1,000 of notes will receive $ 250 face amount of series a 7.5 % senior secured convertible notes due jan. 15 , 1995 , and 200 common shares . for each $ 1,000 face amount of debentures , holders received $ 250 of series b 11 % senior secured convertible notes due oct. 15 , 1998 , and 200 common shares . bio-technology , a new york maker of genetically engineered products for human and animal health care , said 0 it made the exchange offer to reduce its interest payments .